Clarithromycin in pharma franchise in Tamil Nadu

Clarithromycin in PCD pharma franchise in Patna

Clarithromycin in top pharma company in Dehradun

Clarithromycin in pcd pharma supplier in Moradabad

Clarithromycin in phama franchise company in India
Clarithromycin in phama distributor in Kottayam

Home/Products /clindamycin-300mg-capsules

Clinzadin 300 Capsule

Composition : Clindamycin (300mg)

Dosage Form : Capsule

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹317.74/-

Clinzadin 300 Capsule is a pharmaceutical formulation containing 300 mg of clindamycin, an antibiotic that belongs to the lincosamide class. Clindamycin works by inhibiting bacterial protein synthesis, thereby effectively combating a range of bacterial infections. This medication is primarily indicated for the treatment of serious infections caused by anaerobic bacteria, as well as certain types of infections caused by gram-positive cocci, including those found in skin, soft tissue, respiratory, and gynecological infections.

Clindamycin is particularly beneficial for patients allergic to penicillin or those who do not respond well to penicillin-based treatments. It is absorbed well from the gastrointestinal tract and reaches therapeutic levels in the blood and tissues, making it a valuable option for targeted antibiotic therapy. Clinzadin 300 Capsule is usually prescribed as part of a comprehensive treatment plan, which may include other antibiotics or supportive measures, depending on the specific nature of the infection.

When using Clinzadin 300, it is essential to complete the full course of treatment, even if symptoms improve before finishing the medication. This helps prevent the development of antibiotic resistance and ensures the infection is fully eradicated.

Read More

About the Product

Clinzadin 300 Capsule is a pharmaceutical formulation containing 300 mg of clindamycin, an antibiotic that belongs to the lincosamide class. Clindamycin works by inhibiting bacterial protein synthesis, thereby effectively combating a range of bacterial infections. This medication is primarily indicated for the treatment of serious infections caused by anaerobic bacteria, as well as certain types of infections caused by gram-positive cocci, including those found in skin, soft tissue, respiratory, and gynecological infections.

Clindamycin is particularly beneficial for patients allergic to penicillin or those who do not respond well to penicillin-based treatments. It is absorbed well from the gastrointestinal tract and reaches therapeutic levels in the blood and tissues, making it a valuable option for targeted antibiotic therapy. Clinzadin 300 Capsule is usually prescribed as part of a comprehensive treatment plan, which may include other antibiotics or supportive measures, depending on the specific nature of the infection.

When using Clinzadin 300, it is essential to complete the full course of treatment, even if symptoms improve before finishing the medication. This helps prevent the development of antibiotic resistance and ensures the infection is fully eradicated.

Potential side effects include gastrointestinal disturbances, such as diarrhea, nausea, and abdominal pain; allergic reactions are also possible.

Treatment of serious infections caused by anaerobic bacteria and specific gram-positive cocci.

Consult a healthcare professional before use, especially if you have a history of gastrointestinal diseases or allergies to antibiotics.

Store in a cool, dry place, away from direct sunlight and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation